secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xtant Medical Holdings, Inc. (XTNT)
CIK:        0001453593
Form:       8-K
Filed at:   2023-11-09T23:59:59+00:00
Accession:  0001493152-23-039986
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xtant Medical reports record Q3 revenue of $25M, raises FY2023 guidance to $88M-$91M
--------------------------------------------------------------------------------

- Revenue $25.0M, +73% YoY; organic growth 18%; acquisition contributions 55%.
- Net income $9.2M ($0.07 EPS) vs net loss $2.4M ($0.03 loss) in Q3 2022.
- Non-GAAP adjusted EBITDA $0.5M, improved from -$0.9M in prior-year period.
- Gross margin expanded to 61.3% from 54.6% on production efficiencies and product mix.
- FY2023 revenue guidance raised to $88M-$91M from prior $75M-$77M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453593/000149315223039986/0001493152-23-039986-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453593/000149315223039986/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-039986

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer